https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
Flow cytometric analysis revealed that LINC00852 overexpression resulted in a decrease of cells in G0/G1 phase. Moreover, overexpression of LINC00852 affected the expression of epithelial-mesenchymal transition-related proteins. Our data collectively demonstrate that LINC00852 contributes to prostate cancer proliferation and metastasis, indicating that LINC00852is a new promising diagnostic and therapeutic target for treatment of prostate cancer. Our data collectively demonstrate that LINC00852 contributes to prostate cancer
Like
Comment
Share
